Erectile dysfunction (ED) is a widespread condition, the incidence of which is increasing globally. ED is also indicative of underlying vasculopathy and represents a predictor of more serious cardiovascular disorders. Understanding the aetiology of ED may therefore provide invaluable pointers to the pathobiology of other cardiovascular diseases (CVDs) and syndromes. It follows, too, that therapeutic interventions that are successful in treating ED may, ipso facto, be effective in treating the early stages of conditions that include atherosclerosis, angina, plaque rupture and diabetic angiopathy. One common pathological denominator in both CVD and ED is oxidative stress, that is, the overproduction of reactive oxygen species (ROS), in particular, superoxide (O 2 KÀ ) and hydrogen peroxide (H 2 O 2 ). In this review, therefore, we consider the aetiology and pathobiology of O 2 KÀ in promoting ED and focus on NADPH oxidase as an inducible source of O 2 KÀ and H 2 O 2 . Therapeutic strategies aimed at reducing oxidative stress to improve erectile function are also discussed.
Introduction
It has been predicted that erectile dysfunction (ED) will affect one-third of a billion men worldwide by 2025. 1 It has also become increasingly apparent that ED is indicative of underlying vasculopathy and represents a predictor of more serious cardiovascular disorders. [2] [3] [4] [5] [6] Understanding the aetiology of ED may therefore provide invaluable pointers to the pathobiology of other cardiovascular diseases (CVDs) and related syndromes. It follows, too, that therapeutic interventions that are successful in treating ED may, ipso facto, be effective in treating the early stages of CVDs including atherosclerosis, angina, plaque rupture, hypertension and diabetic angiopathy.
Several studies have now indicated a central role for reactive oxygen species (ROS) in the aetiology of ED, principally through the reaction of superoxide (O 2 KÀ ) with nitric oxide (NO K ), resulting not only in acute impairment of cavernosal relaxation but also long-term penile vasculopathy. ROS have also been implicated in both neurogenic ED and vasculogenic ED. As ROS are also implicated in CVDs, this indicates that ROS may be the common denominator lesion in both ED and CVD.
The objective of this article, therefore, is to review the pathophysiological role of ROS in ED with particular emphasis in NADPH oxidase and O 2 KÀ and possible therapeutic strategies that would not only improve erectile function acutely but also prevent ED in the longer term. Before discussing these topics, an overview of normal penile erection is presented for those not familiar with the topic.
Normal erection: the central role of nitric oxide
Penile erection is elicited by a physiologically unique sequence of events. [7] [8] [9] [10] [11] [12] On male sexual arousal, higher cerebral centres in the paraventricular nucleus of the hypothalamus and limbic system are activated. 10, 11 Central neurotransmitters implicated in the control of erections include dopamine, serotonin, noradrenaline, opioids, oxytocin, prolactin and gamma-aminobutyric acid. The precise role of these central pathways in erectile physiology has been difficult to verify as the central nervous system also controls other components of sexual activity, including arousal and copulation. Evidence from animal experiments and studies in patients with spinal cord injuries, however, have established that a sacral spinal reflex pathway controls erection. 10, 11 This spinal mechanism involves pudendal nerve afferent pathways communicating via interneurones to preganglionic parasympathetic neurones in the dorsal horn of the sacral spinal cord (S2-S4). 10, 11 These efferent parasympathetic (cholinergic) fibres reach the penis via the pelvic plexus and the cavernosal nerves and their activation leads to erection. Sympathetic fibres derived from the thoraco-lumbar spinal cord (T10-L2), via the superior hypogastric and pelvic plexus, are implicated in both detumescence and ejaculation. 10, 11 The increase in the activity of nerves supplying smooth muscle in the penile arteries and corpus cavernosum results in their relaxation and therefore erection ( Figure 1) . In a series of elegant studies, the unique hemodynamics of erection has been elucidated. [12] [13] [14] [15] [16] [17] [18] [19] [20] The compliance of the corpora increases and arterial resistance decreases, exposing the sinusoids to systemic blood pressure and leading to engorgement of blood in the corpus cavernosum ( Figure 1 ). As inflow increases and sinusoidal smooth muscle relaxes, subtunical venules draining the corpus cavernosal tissue become compressed Figure 1 Principal events involved in mediating penile erection. Following sexual arousal, non-adrenergic non-cholinergic (NANC) fibres release NO in both pudendal arteries and cavernosal smooth muscle. NO is also released from the vascular endothelium of these tissues. NO elicits relaxation of the arteries and cavernosum, which results in a greater inflow of blood relative to outflow. As a consequence, the subtunical venules are compressed against the tunica albuginea resulting in veno-occlusion and a rise in intracavernosal pressure and erection ensues. derived from endothelial nitric oxide synthase (eNOS) also plays a role but apparently to a lesser degree than nitrergic fibres. [23] [24] [25] However, blood-flowinduced fluid shear stress in the penile vasculature stimulates phosphatidyl-inositol 3-kinase (PI3K) which phosphorylates protein kinase B (PKB), which in turn phosphorylates eNOS to also generate NO K . 26 Given the dramatic alterations in penile flow during erection, this may represent a key mechanism that links nNOS to eNOS. It has been suggested, therefore, that nNOS provides the initial dilatory trigger and NO derived from eNOS maintains erection during sexual congress. [27] [28] [29] It should be stressed, however, that nNOS-and eNOSdeficient mice maintain erectile function and reproductive capacity, observations that have brought into question the importance of NO K . 27, 28 Furthermore, in a recent study, it was demonstrated in nNOS-deficient mice that a (b) splice variant of nNOS elicits erection despite a decrease in erectile response and a marked increase in sensitivity to the NOS inhibitor, N G -nitro-L-arginine methyl ester. 29 It should also be emphasized that adaption to the loss of any given function in a gene deficient mouse may elicit the upregulation of alternative biosystems that compensate for the loss of a primary mediator (in this case NO K derived from NOS). Thus, the further study of erection in nNOS-and eNOS-deficient mice may therefore reveal other important mediatory pathways (as was the case for the discovery of splice variants of nNOS) that would otherwise not be apparent in other models.
FLACCID ERECT
Nangle et al. 30 demonstrated in nNOS-deficient mice that aortic relaxation was impaired in response to electrical field stimulation (EFS: activates nitrergic nerves), albeit to a lesser degree than cavernosal tissue and suggested that aorta function may be at least partially reliant on nNOS-related mechanisms. Nitrergic innervation may also influence dilation of pudendal and penile arteries. Such a possibility warrants further study.
Irrespective (perhaps) of its source, NO K diffuses into VSMCs and activates soluble guanylyl cyclase (sGC) to generate cyclic guanosine monophosphate (cGMP), which activates protein kinase G (PKG) isoforms. 31 PKG acts by phosphorylating proteins that modulate cellular function. Principally, in terms of actute erection, these include the inhibition of calcium mobilization both from intracellular stores (the sarcoplasmic reticulum), surface calcium channels and potassium channels linked to calcium influx, thereby eliciting vascular relaxation and therefore erection. 31 Apart from relaxation, the NO-cGMP-PKG system controls other functions that protect against vascular disease in the longer term. These include the inhibition of adhesion molecule expression, lipid oxidation, matrix protein synthesis and deposition (fibrosis), VSMC proliferation, protection against apoptosis and inhibition of oxidative stress itself. [32] [33] [34] The importance of the NO-cGMP-PKG axis in mediating erection is exemplified by the therapeutic action of the phosphodiesterase type 5 (PDE5) inhibitors such as sildenafil (Viagra), vardenafil and tadalafil in eliciting erection in patients with ED. 9, [35] [36] [37] [38] [39] [40] These drugs act by inhibiting PDE5, an enzyme that breaks down cyclic GMP to inactive GMP, thereby augmenting cGMP levels and therefore relaxation elicited by NO. In this context, Cashen et al. 40 demonstrated that sildenafil failed to augment erection in nNOS-deficient mice but was effective in eNOS-deficient mice. Although this consolidates that the principal action of sildenafil is at the level of neurally generated NO, this is something of a puzzle since sildenafil acts on PDE5 at the VSMC level. Why should sildenafil promote erection only in response to NO K derived from nNOS and not from eNOS? Perhaps, the action of PDE5 inhibitors is centred at the neuromuscular level by a hitherto unrecognized mechanism. As will be discussed later we have demonstrated that PDE5 inhibitors also directly influence the formation of ROS in cavernosal cells and tissues, [41] [42] [43] which may constitute an alternative or additional mode of action for this class of drug.
enzymes that have oxygen as one of their substrates. 44 The 32, 33, 59 all conditions that predispose to both CVD and ED.
There are few studies on the direct effects and mechanism of action O 2 KÀ on isolated penile tissues. However, impairment of acetylcholine-dependent relaxation in rat cavernosal smooth muscle by the O 2 K donor, pyrogallol has been demonstrated. 60 By contrast, in the bovine retractor penis muscle O 2 K generating agents (including pyrogallol) had no effect on NANC-mediated relaxation. 60 However, the copper chelator, diethyldithiocarbamic acid (negates superoxide dismutase (SOD) activity by chelation of copper) did render the tissue inhibi- 64 Posttranslational regulation of both NOS isoforms that are susceptible to ROS attack include phosphorylation and acylation, cofactors and substrates, as well as subcellular localization at the plasma membrane, caveolae, Golgi, mitochondria and intercellular junction. [65] [66] [67] [68] [69] [70] [71] [72] eNOS, nNOS and iNOS, are all homodimers, with each of the two subunits having a bidomain structure consisting of an N-terminal oxygenase domain containing a heme moiety and binding sites for zinc, arginine and the cofactor, tetrahydrobiopterin. A C-terminal reductase domain contains binding sites for FAD, FMN and NADPH. Located between the oxygenase and reductase domains is a Ca 2 þ calmodulin (CaM) binding sequence. eNOS also requires CaM, which binds to calcium complex then interacts with eNOS to augment activity and NO K release. Five serine/ threonine sites of phosphorylation of bovine eNOS have been identified at ser-116, thr-497, ser-617, ser-635 and ser-1179. [66] [67] [68] [69] [70] [71] [72] Phosphorylation at ser-1179 and ser-635 increases eNOS activity, whereas phosphorylation at ser-617 does not alter maximal activity but significantly increases the Ca 2 þ -CaM sensitivity of the enzyme. In contrast, eNOS phosphorylation at thr-497 within the CaM binding sequence reduces eNOS catalytic activity by decreasing the binding affinity for Ca 2 þ -CaM. Protein phosphatases 1 (PPI) and 2A (2A) also regulate eNOS. PP1 dephosphorylates thr-497 in response to vasodilators via a Ca 2 þ -dependent mechanism, promoting eNOS activity. 70 In turn, ROS elicit a marked influence of phosphorylation/dephosphorylation status of mediator proteins. 73, 74 Others kinases that modulate NOS activity include protein kinase A (PKA), PKG and AMP kinase. 75 Phosphorylation of eNOS by cGMP-and cAMPdependent protein kinases not only stimulates Ca 2 þ / CaM-dependent eNOS activity, but also causes a Ca 2 þ -independent partial activation of eNOS that does not appear to involve enzyme translocation to the cytosol. 75 Since ROS decrease bioavailability of NO this in turn would diminish PKG activation, the PKG-eNOS pathway may further contribute to ED (see PKA in relation to eicosanoids later).
PKC downregulates eNOS activity through phosphorylation of thr-497. 76 ROS activates PKC which would impact by decreasing eNOS activity. Interestingly, PKC also activates NADPH oxidase (see later). Akt protein kinase (aka PKB) is another important activator of eNOS that activates phosphatidylinositol 3-kinase (PI3) kinase. 77 Src kinase also activates eNOS. 78 Caveolin-1 is another major regulator of NOS. An increase in [Ca 2 þ ] i causes caveolin to dissociate from eNOS, which then allows for binding of activated CaM-Ca 2 þ thereby increasing eNOS activity. 69 In turn, ROS not only decreases eNOS expression but disturbs the association of eNOS with caveolin, thereby decreasing its activity. 79 An important intracellular signalling system that is activated by ROS is the Rho/Rho kinase pathway. ROS elicits vasoconstriction through activation of the Rho/Rho kinase pathway resulting in calcium sensitization. [80] [81] [82] As Rho GTPase also inhibits eNOS expression, 81 then ROS may elicit ED through a dualistic inhibition of eNOS and promotion of cavernosal constriction. The Rho/Rho-kinase pathway also controls actin cytoskeleton organization, cell adhesion and motility, cytokinesis and gene expression and accelerates inflammation, oxidative stress, thrombus formation and fibrosis, all components of ED. ROS also influence gene and protein expression by activating transcription factors, such as NF-kB, activator protein-1 (AP-1) and hypoxia-inducible factor-1 (HIF-1). 63, 85 Oxidative stress activates NF-kB-mediated transcription of proinflammatory mediators either through activation of its activating inhibitor of kB-alpha kinase or the enhanced recruitment and activation of transcriptional coactivators. 85 Enhanced NF-kB-coactivator complex formation results in targeted increases in histone modifications, such as acetylation leading to inflammatory gene expression. 85 Activation of the Janus family of tyrosine kinases (JAK)/STAT pathway has also been observed in response to intracellular ROS 86 and exogenous H 2 O 2. 87 On phosphorylation by JAKs of tyrosine residues, activated STAT dimers translocate to the nucleus to transactivate target gene expression. 88 ROS also activate Poly (ADP-ribose) polymerase (PARP), an abundant nuclear enzyme that mediates DNA injury and cell death. 89 PARP is a nuclear nick sensor enzyme that becomes activated in response to DNA damage. In turn, excessive activation of PARP depletes the cellular NAD þ and adenosine triphosphate pools and causes necrotic cell death. 89 (NOX reviews) All these factors have been implicated in the aetiology ED, as will become apparent as the review progresses.
NADPH oxidase
One key facet of NADPH oxidase is that its expression, in response to inflammogens, is blocked by NO derived from eNOS. 102 It was suggested, therefore, that NO may act protectively to prevent NADPH oxidase expression in response to the factors that promote its expression. 103, 104 By contrast, the downregulation or impairment of eNOS activity, a possibly key event in ED, would render vascular tissue more susceptible to an increase in NADPH oxidase. Similarly, since NADPH oxidase generates O 2 KÀ which negates NO K bioactivity, then this may constitute a self-perpetuating mechanism that would promote oxidative stress in penile tissue and related vasculature (Figure 2) .
The potentially crucial role played by NADPH oxidase in ED is exemplified by the in vitro effect of sildenafil on NADPH oxidase expression and O 2 KÀ formation ( Figure 3 ). Sildenafil is a potent inhibitor of NADPH oxidase expression through augmentation of the NO-cGMP-PKG axis in both pulmonary artery and penile vascular cells [41] [42] [43] (Figure 4 ). By reducing O 2 KÀ release, sildenafil therefore augments NO bioavailability which would, ipso facto, augment erection. Furthermore, an NO-donating derivative of sildenafil (NCX 911) was even more potent at inhibiting NADPH oxidase (gp91 phox ) expression in endothelial cells and cavernosal tissue, [41] [42] [43] a facet attributable to the simultaneous provision of NO drive by the drug. 41 More recently we have established that NO K inhibits the acute activation of NADPH oxidase, principally through 
Risk factors for ED: role of oxygen-free radicals
The link between ED and diffuse vascular disease was first recognized by Michal 105 who reported that disturbance of arterial or venous function as a consequence of atherosclerosis leads to male impotence. Virag et al. 106 later described a clear synergistic relationship between cardiovascular risk factors and the likelihood of arteriogenic ED. Since then, many epidemiological studies have established that risk factors for CVDs are identical to those for ED. Principal among these risk factors are DM, hypercholesterolaemia (HcH), dyslipidaemia, cigarette smoking, hypertension and possibly HHC. [2] [3] [4] [5] [6] This association points to a common aetiology in both scenarios.
It is now an established paradigm that endothelial dysfunction is a primary (early) lesion in the development of vascular diseases. In the case of atherosclerosis, a dysfunctional endothelium (in particular diminished NO formation) results in the adhesion and infiltration of monocytes which become resident macrophages, then foam cells, the epicentres of atherosclerotic plaques. 107 Reduced NO is associated clinically with HcH, DM, dyslipidaemia, cigarette smoking, hypertension and HHC.
In turn, the intravascular overproduction of ROS, in particular, O 2 KÀ , has been demonstrated in all the aforementioned conditions. As O 2 KÀ negates NO bioavailability, this points to an overproduction of O 2 KÀ as the primary and early lesion in the progression of both CVD and ED. It has also been advocated that increased NADPH-oxidase-mediated O 2 KÀ production in the early stages of atherosclerosis 108, 109 and is central to the aetiology of all CVDs. 46, 59 HcH, ED and ROS HcH and dyslipidaemia are well-established major risk factors for ED. 2, [80] [81] [82] [83] [84] [110] [111] [112] [113] [114] [115] Experimental animal models have demonstrated that HcH promotes ED at both the cavernosal and pudendal arterial levels. [110] [111] [112] [113] [114] [115] Thus, atherosclerotic lesions within the pudendal arteries reduce blood inflow which in turn impairs erectile function, inflow relative KÀ derived from NADPH oxidase would also result in the greater formation of isoprostanes which upregulate NADPH oxidase resulting again in a self-perpetuating loop. Isoprostanes are vasoconstrictors that would independently augment ED. Again, PGI 2 would be reduced. Furthermore, these events would indirectly result in reduced NO formation and therefore ED.
ROS and
to outflow of blood being axiomatic in erection. Occlusive (pudendal) arterial disease is therefore recognized as a leading cause of ED. 114 In turn, HcH elicits impaired endothelium-dependent relaxation by cavernosal and pudendal arteries through a reduction of NO K bioavailability. 115 Notably, in these models, endothelial dysfunction precedes overt atherosclerosis. 111 It is now widely accepted that a principal cause of reduced NO K in Hch is increased O 2 KÀ formation. 116 Impaired cavernosal relaxation responses were associated with raised cavernosal tissue O 2 KÀ formation in rabbits fed a high cholesterol diet for 2 months. 113 In the same study, an increase in the activity of cavernosal SOD was also observed, indicating that despite an increase in this important antioxidant enzyme, an upregulation of O 2 KÀ generating systems 'overrides' this adaptive increase in SOD. 113 O 2 KÀ formation by cavernosal tissue from hypercholesterolaemic rabbits is blocked by NADPH oxidase inhibitors. 41 NADPH oxidase inhibitors also reverses the inhibitory impact of HcH on cavernosal relaxation. 41 It was concluded that O 2 KÀ derived from NADPH oxidase plays a central role in mediating ED in the hypercholesterolaemic rabbit.
Furthermore, both sildenafil citrate and NCX 911 (NO-donating sildenafil) also reversed impaired carbachol-stimulated relaxation and inhibited O 2 KÀ formation by cavernosal tissue from hypercholesterolaemic rabbits, NCX 911 being more potent. 41 NCX 911 also augmented cavernosal cGMP levels, an effect blocked by the guanylyl cyclase inhibition. 42 These data indicate that NO-donating sildenafil may be therapeutically more beneficial than conventional sildenafil in treating ED with an oxidative stress-related aetiology.
By contrast, HcH appears not to exert an impact on neurally mediated erection, at least not in experimental animal models. This is something of a conundrum since HcH is firmly associated with ED but not neuropathic ED (as in DM; see below). This facet perhaps illustrates that although nitrergic innervation is deemed axiomatic to the therapeutic impact of PDE5 inhibitors, that endothelial NO K may be (at least) equally important as NO derived from nitrergic fibres.
Intriguingly, and somewhat paradoxically, statins (i.e. cholesterol lowering drugs) have been reported to promote ED. 117 However, Nangle et al. 118 demonstrated that statin treatment corrected defective NO K -mediated (NANC and endothelium dependent) cavernosal and vascular function in diabetic mice. This effect was independent of cholesterol lowering but may have been dependent on the inhibition of cholesterol biosynthesis pathway. 118 Osborne demonstrated that statin treatment improves ED in sildenafil nonresponders, 119 whereas Solmon et al. 120 found that ED was worsened by statin treatment in high cardiovascular risk patients. We are at a loss to explain the diametrically opposite findings, especially as statins improve endothelial function, increase NO K formation but reduce NADPH oxidase activity and O 2 KÀ formation. 121 It may be therefore that statins elicit negative effects on other pathways important to erectile function or that the metabolic status and or severity of the underlying CVD is axiomatic in whether statins are beneficial or not.
Diabetes mellitus DM is a major (if not the principal) risk factor for both ED and CVD [122] [123] [124] [125] [126] and is associated with both neuropathy and endothelial dysfunction, both cardinal risk factors for ED and diabetic angiopathy. The metabolic syndrome, the criteria for which include glucose intolerance, obesity, hypertension and dyslipidaemia, is now associated with ED. 127 Both NANC-mediated and endothelium-dependant relaxation of the corpus cavernosum are impaired in diabetic patients 128 and animal models. [129] [130] [131] [132] [133] Impaired vascular NO K formation is also now classically associated with DM. 134 The restoration of impaired cavernosal relaxation in both diabetic rats and rabbits by the long-term administration of 133 also demonstrated that sildenafil was effective in mediating both NANC and endothelium-dependent relaxation of cavernosal tissue erection in diabetic rabbits. These data are of interest since there is controversy concerning the relative roles of eNOS an iNOS in mediating diabetic ED. DM is also associated with increased intravascular NADPH oxidase activity. 134 DM is classically associated with neuropathy which in turn is a major determinant of diabetic ED. Short-term hyperglycaemia produces oxidative damage and apoptosis in neurons which may relate to neuropathic ED. 138 A link between impaired microvascular blood supply (microangiopathy) and diabetic neuropathy is also now well established. 126 In turn, ROS impair microvascular function. 139 In diabetic animal models, impaired microvascular blood flow is associated with sciatic nerve dysfunction. [140] [141] [142] [143] [144] In one elegant study, it was shown that preventing O 2 KÀ formation in epineural arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation. 144 This latter study indicates that O 2 KÀ formation by the vasa nervorum has a knock-on effect of promoting neural dysfunction.
In another context, disruption of the vasa vasorum, the microvessel complex that supplies blood to larger conduit arteries, results in arteriopathy, probably though eliciting hypoxic stress in the artery. 145, 146 It is not unreasonable to suggest, therefore, that impairment of the normal function of the vasa vasorum that supplies the pudendal arteries may contribute to the progression of ED.
Homocysteine and transition metals HHC, which can be mild, moderate or severe is a risk factor for CVD. 147 Since many studies have now demonstrated that HHC promotes angiopathy through inhibition of NO formation, 148 it follows that HHC may be a risk factor for ED. Although no clinical studies have yet established an association for ED, severe HHC in the rabbit induced by dietary methionine (the precursor of homocysteine (Hcy)), results in a marked impairment of endothelium dependent, but not of electrically stimulated, relaxation of the cavernosal smooth muscle. 149 Furthermore, in keeping with the pattern of ROS in other risk factors, HHC resulted in an upregulation of vascular NADPH oxidase expression in cavernosal tissue. 150 Although the angiopathic effect of Hcy is thought to be mediated by the auto-oxidation of Hcy to form O 2 À and H 2 O 2, 151 Hcy alone may not be vasculopathic. Hcy at up to 1 mM, Hcy has no effect on the relaxation of cavernosal or arterial tissue, in vitro, 152, 153 indicating the involvement of another factor, in vivo. The generation of O 2 KÀ from Hcy is augmented by copper ions via Fenton and HaberWeiss reactions. 154 Thus it was found that Hcy interacts with copper to Hcy impairs endotheliumdependent relaxation in the rabbit cavernosum. 152, 153 This inhibitory effect was reversed by both SOD and catalase, suggesting both O 2 KÀ and H 2 O 2 mediated this effect of Hcy and copper together. In a more recent in vivo study it was demonstrated that administration of penicillamine, a copper chelator, reversed the impairment of endothelium-dependent relaxation, O 2 KÀ formation and NADPH oxidase upregulation in both cavernosal and arterial tissue elicited by experimental HHC. 150 This consolidates the concept that the vasculopathic impact of Hcy is mediated ultimately by copper, in vivo. Furthermore, copper itself has been shown to augment impair endothelium-dependent relaxation in the diabetic rabbit. 154 Under normal circumstances, copper is tightly bound to plasma proteins including ceruloplasmin and as such free cooper is never available to enter into oxidative reactions. 155 However, it appears that oxidative stress liberates copper from its binding sites. In turn this allows copper to augment redox reactions, including the oxidation of Hcy. 155 Furthermore, copper bound to CP and other proteins can still catalyze oxidative reactions, including the oxidation of low-density lipoprotein and reactions with aminothiols, such as Hcy. 155 HHC interacts with other risk factors to promote vasculopathy. In particular, Hcy has been associated with the degree and severity of vascular disease shown to operate synergistically in non-penile vascular tissues. 156, 157 Hypertension, diet and lifestyle Hypertension is another major risk factor for ED 158 and is associated with impaired NO K formation at the vascular-endothelial level. 159 In turn, NADPH oxidase has been associated with various forms of hypertension but less is known of the enzyme status in patients with hypertension and ED or of neurally generated NO. 160, 161 There is also evidence that centrally acting sympatholytic agents, beta-adrenoceptor antagonists and diuretics may further impair sexual function, although this view is being contested. [162] [163] [164] Interestingly, angiotensin II receptor antagonists may even improve sexual function 165 and angiotensin II is both a potent activator of NADPH oxidase and that ANG II receptor angiotensin II receptor antagonists prevent the formation of O 2 KÀ . 52, 53 However, few studies have been carried out demonstrate a clear relationship between hypertension, ED and ROS but nevertheless warrants further study. Diet and lifestyle, which has an enormous impact on the incidence of CVD are now becoming more and more associated with ED. 166, 167 These broad factors include the high fat or 'Western' diet, obesity, physical inactivity, consumption of alcohol and coffee and cigarette smoking and recreational drugs, such as cocaine. [167] [168] [169] Cigarette smoking has long been associated with ED 169 and in keeping with the seemingly common denominator role of NADPH oxidase in risk factors, nicotine upregulates NADPH oxidase expression in cavernosal VSMCs. 170 
Ischaemia and hypoxia
Owing to the unique haemodynamics of erection, the penile circulation is subject to marked alterations in tissue oxygenation status that may influence erectile function not only acutely by eliciting vasoconstriction but also in the longer term by promoting vascular lesions in pudendal arteries and penile fibrosis. [171] [172] [173] [174] [175] [176] Low oxygen tensions are basally present in corpus cavernosum in the flaccid state 176 and cavernosal oxygen tension increases during erection. 176 Indeed, a cavernosal oxygen tension of at least 65 mm Hg is required for sufficient cavernosal perfusion and erection. 176 Experimentally induced atherosclerotic lesions of the pudendal arteries results in arterial insufficiency, hemodynamic impairment and chronic exposure of penile tissues to hypoxia/ ischaemia. [171] [172] [173] [174] These, in turn promote alterations of function and structure which further impair the inflow relative to outflow of blood into the corpus cavernosum. In an ischaemic model in which the artery is injured in atherosclerotic rabbits there is diffuse atherosclerotic occlusive disease and a significant decrease in iliac arterial and intracavernosal blood flow. 111 Kim et al. 174 reported that hypoxia in both rabbit and human cavernosal tissue reduces NO K -mediated, neurogenic and endothelium-dependent relaxation. In addition to impairing smooth muscle relaxation, ischaemia directly increases contraction of erectile tissue. [171] [172] [173] Ischaemia/hypoxia acutely increase the formation of ROS including O 2 KÀ from disparate sources including the mitochondrial respiratory chain, xanthine oxidase, NADPH oxidase, NOS isoforms and the COX enzymes. 177, 178 Hypoxia elicits a marked increase in NADPH oxidase expression in endothelial cells which results in an increase in O 2 KÀ release. 95 In turn O 2 KÀ autoaugments the formation of O 2 KÀ through upregulation of NADPH oxidase, 101 which would readily explain this effect. Thus, virtually instantaneously, hypoxia may elicit ED by locally negating NO K bioavailability at both the endothelial and neural level, as well directly eliciting vasoconstriction through the mobilization of calcium. It is likely, too, that such cascades (including augmented vasoconstriction) would worsen hypoxia and result in the generation of more ROS, thereby creating a self-amplifying loop that would worsen and augment ED, acutely.
Prolonged hypoxia, as would occur in obstructive ischaemic arterial disease, upregulates the expression of literally hundreds of proteins. 177 For example, hypoxia upregulates eNOS and NADPH oxidase expression simultaneously in endothelial cells within hours. 95 However, the concomitant formation of O 2 KÀ would negate this effect of increasing NOS expression and activity. As mentioned, O 2 KÀ itself upregulates the expression of NAPDH oxidase in endothelial cells. 101 Yet again, a self-perpetuating loop would ensue that may result in ED.
The erection-detumescence cycle may therefore represent an ischaemia-reperfusion type scenario, which is now classically associated with an overproduction of ROS and an induction of NADPH oxidase expression. 178 In this context, it was demonstrated that sildenafil reduces ischaemia reperfusion injury in cardiac tissue. 179 It is possible that sildenafil may also act, at least in part, by blocking ROS formation in the penile circulation. Intriguingly, pulmonary conditions associated with hypoxia, such as chronic obstructive airways disease, pulmonary fibrosis and obstructive sleep apnoea are associated with ED. 180 In turn long-term oxygen therapy improves erectile function in such patients. 181 
ROS and eicosanoids
ROS elicit a marked disruption of eicosanoid balance in vascular tissues. 32, 33, 98 Penile tissue and arterial tissue produce a battery of prostanoids that have opposing actions: principally, prostacyclin (PGI 2 ) and TXA 2 .
182-184 PGI 2 possesses identical properties to prostaglandin E 1 , which classically evokes erection following intracavernosal injection. 185, 186 It was demonstrated some time ago that the formation of PGI 2 in cavernosal tissue is reduced in conditions that predispose to ED. [187] [188] [189] [190] [191] The administration of PGI 2 analogues, such as iloprost, have long been known to elicit vasculoprotective effects. 192 The administration of the PGI 2 analogue, beraprost, prevented the development of severe neuropathy in diabetic rats. 193 Although it is now generally accepted that PGI 2 is not a specific erectogen, as is the case for NO K , it is likely to have a protective role in preventing arterial and cavernosal disease.
186 PGI 2 possesses many vasculoprotective properties to NO that include the prevention of adhesion of blood cells, accumulation of cholesterol and the inhibition of VSMC proliferation. 186 In parallel with the NO-cGMP-PKG system, PGI 2 elicits these effects through the cAMP-PKA pathway. 186 PGI 2 is also a potent inhibitor of NADPH oxidase expression, 98 adding to its repertoire of protective attributes shared by NO. By contrast, NADPH oxidase results in a depletion of PGI 2 formation, possibly either as result of nitration of PGI 2 synthase or rechanneling of arachidonic acid metabolism (Figure 3 ) In turn, the activity and expression of NADPH oxidase, by virtue of generating O 2 KÀ reduces PGI 2 formation in part through negation of PGI 2 synthase activity. 98 Such a defect in the capacity to produce PGI 2 may tend toward augmentation of NADPH oxidase activity and expression, and therefore, a worsening of oxidative pathology.
By contrast to PGI 2 , endogenous TXA 2 is a potent vasoconstrictor and promoter of inflammation and as such has been widely implicated in the aetiology of ED. 186 Studies have shown that the inhibition of TXA 2 formation improves experimental ED. 194, 195 In this context, TXA 2 is a potent promoter of activity and expression of NADPH oxidase and O 2 KÀ formation in cavernosal and arterial tissue. 98 ROS also promote the formation of 8-isoprostanes, which have identical properties to TXA 2 in that they are potent vasoconstrictors and promoters of platelet activity. 196 As a consequence of the greater formation of 8-isoprostanes there is a reduction of PGI 2 formation. 98 8-isoprostanes upregulate the expression of NADPH oxidase in arterial cells and tissues. 98 In turn, PGI 2 blocks NADPH oxidase expression elicited by TXA 2 and 8-isoprostane. 98 It is tempting to speculate, therefore, that oxidative status alters the balance between eicosanoids of diametrically opposing properties which in turn promotes vasculopathy and ED (Figure 3 ).
Oxygen-free radicals and neuropathic ED
Apart from the link between ROS and endothelial dysfunction in cavernosal and pudendal arteries, there is also evidence that ROS promote neuropathic ED associated with DM. 126, 197 Certainly, ROS are associated with diabetic neuropathy. 91, 197 Neurocytes themselves generate ROS, which in turn can elicit direct cytotoxic or apoptotic effects on neurocytes, 198 short-term hyperglycaemia having been shown to promote oxidative damage and apoptosis in neurons (1999) . NADPH oxidase may play a central role in neuropathy. For example, O 2 KÀ derived from NADPH oxidase in glial cells interacts with NO to induce neuronal death. 199 NADPH oxidase activity has been shown to be elevated in sympathetic neurones from hypertensive rats. 200 As mentioned, apocynin improves impaired neural function in diabetic rats. 91 Dysfunction of the normal vasa nervorum (i.e. microvascular supply to nerves) plays a role in mediating neuropathic ED. [201] [202] [203] In experimental diabetic models, impaired microvascular blood flow is associated with nerve dysfunction 202 which may result in hypoxia which in turn would promote neural (nitrergic) dysfunction.
Therapeutic implications
Although PDE5 inhibitors have revolutionized the acute treatment of ED there is no treatment that reverses or prevents the progression of ED. The ageold maxim that prevention is better than cure holds true for ED as it does for any other disease. The treatment of ED has also taken on new importance in that ED is a predictor of more serious CVDs. [4] [5] [6] It follows, also, that those therapies that prove successful in preventing in ED may prevent longer term CVDs that include atherogenesis, myocardial infarction and stroke.
The preceding review of the literature provides strong evidence that O 2 KÀ and other ROS elicit ED acutely through negation of NO bioactivity, neural dysfunction and direct vasoconstriction. In the longer term O 2 KÀ and other ROS elicit atherogenesis and negation of the vasculoprotection afforded by NO and PGI 2 . The overproduction of O 2 KÀ is also associated with all those risk factors that predispose to ED.
From a therapeutic perspective, therefore, the inhibition of O 2 KÀ formation or its negation (quenching) constitutes a potentially valid approach to the prevention and treatment of ED, both acutely and in the long term. Drugs that do so are generally termed 'antioxidants'. The diversity and number of antioxidants that have been shown to ameliorate ED in animal models is considerable and include: vitamins C, D and E, pomegranate juice, selenate, metal (iron and copper) chelators, probucol, M40403 and SOD mimetics. 92, 136, 144, 150, [204] [205] [206] [207] [208] [209] Despite these encouraging data derived from preclinical studies, no randomized controlled studies of antioxidant administration to patients with ED have so far been reported. By contrast, the study of antioxidant vitamins, including vitamins C and E have been widely studied in treating CVD but have proven disappointing. 32 A possible reason for the discrepancy between improvements in vascular function by antioxidants in animal models and human studies is that the disease was treated at a more advanced stage in clinical studies. Put another way, antioxidant therapy may be a case of 'shutting the therapeutic door when the pathological horse has bolted'. Furthermore, the synergistic effect of multiple risk factors or other dietary or In this review we have provided evidence that a common denominator lesion in both ED and CVD may be the overexpression of NADPH oxidase in penile and associated arterial tissue. Indeed, the finding that sildenafil is a potent inhibitor of NADPH oxidase expression and activity [41] [42] [43] consolidates the potentially central role of NAPDH oxidase in mediating acute ED. Repeated administration of sildenafil improves erectile and endothelial function in a rat model of diabetes, indicating that the prolonged inhibition of NADPH oxidase activity and therefore the prevention of NO bioavailability. 210 Another study demonstrated that vitamin E significantly enhances the effect of sildenafil when coadministered in this animal model. 211 One important facet of NAPDH oxidase status is that it is activated acutely to release O 2 KÀ by factors associated with ED, principally vasoconstrictors (angiotensin II (ANG II), TXA 2 , endothelin-1). It would be intriguing to determine whether the principal or additional effect of these drugs is mediated by inhibition of NAPDH oxidase activity. Likewise, the upregulation of NAPDH oxidase (and therefore chronic increase in upregulation of the enzyme) is striking and range from the above constrictors to cytokines hypoxia and O 2 KÀ itself. Drugs that inhibit NAPDH oxidase expression and activity include iloprost, NO K donors, prednisolone, ACE inhibitors (reduce ANG II formation). 34 As NADPH oxidase generates O 2 KÀ it is implicit that the vasculopathic impact of the enzyme would be negated by drugs that remove O 2
KÀ
, that is, SOD and SOD mimetics and antioxidants. 212 As mentioned, O 2 KÀ itself upregulates NAPDH oxidase expression which represents a positive feedback loop that would autoaugment the expression of NAPDH oxidase. 34 It follows that drugs that quench O 2 KÀ or prevent its formation would prevent this positive feedback loop (Figure 2 ). Specific inhibitors of NAPDH oxidase include drugs such as apocynin and diphenyl iodonium chloride 212 and more recently, VAS2870. 213 As noted earlier, the administration of apocynin to animal models reverses or blocks the angiopathic and neuropathic impact of DM. 90, 91 Not only do these studies exemplify the possible key role played by NAPDH oxidase in vasculopathy but also the therapeutic potential of NADPH oxidase inhibition.
Concluding remarks
There is now considerable evidence that O 2 KÀ derived from NADPH oxidase and other sources promotes ED at several key levels, including the endothelial cells that line the cavernosum and pudendal arteries, neural tissue and microvessels that supply both neural and arterial tissues. In turn, there is a large array of disparate drug types that prevent the formation of O 2 KÀ (or quench it) and improve erectile function, at least in experimental models. There is a remarkable paucity of data relating to effects of these diverse regimes in patients with ED, however, and as such clinical trials are urgently needed. Given that many of the substances that may prove effective in treating ED are relatively innocuous and are actually naturally occurring (e.g. pomegranate juice, folic acid, fatty acids, vitamins), then clinical trials are likely to be more straightforward than with 'hard core' pharmacological agents. Furthermore, ED has now taken on considerable importance since it is now recognized that ED is indicative of underlying vasculopathy and represents a predictor of more serious cardiovascular disorders. [2] [3] [4] [5] [6] Understanding the aetiology of ED may therefore provide pointers to the pathobiology of other CVDs and related syndromes. It follows, too, that therapeutic interventions that are successful in treating ED may be effective in treating the early stages of conditions that include atherosclerosis, angina, plaque rupture, hypertension and diabetic angiopathy. Certainly, for researchers into ED, this represents a considerable but potentially hugely rewarding avenue for future endeavours.
